Catalyst Wire Dossier Catalyst Wire Dossier

HRS9531 Injection

HRS9531 · Fujian Shengdi Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HRS9531 Injection, covering 2024-08-22 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function [Phase 1]

See pricing